New Launch22 May 2025, 01:25 pm
Gennex Subsidiary, Deccan Remedies, Receives Approval for Manufacturing Additional Products in Andhra Pradesh
AI Summary
Gennex Laboratories Ltd. is pleased to announce that their subsidiary company, Deccan Remedies Limited, has received approvals from the Drugs Control Administration, Government of Andhra Pradesh, for the manufacture of additional products under Form 25. The approved products include Tapentadol Hydrochloride, Etoricoxib, and Nitazoxanide, and are valid up to May 28, 2028, for both domestic and export purposes. The approval letter also outlines specific conditions for manufacturing and export, including compliance with drug price control orders, labeling provisions, and federal regulations of importing countries.
Key Highlights
- Deccan Remedies Limited received approvals for manufacturing additional products under Form 25
- The approved products include Tapentadol Hydrochloride, Etoricoxib, and Nitazoxanide
- The approvals are valid up to May 28, 2028, for both domestic and export purposes
- The approval is subject to specific conditions and compliance with drug price control orders and federal regulations
- Detailed particulars of rejects/returned goods shall be furnished to the Drugs Control Administration